Observational studyPharmacoepidemiology and drug safety2018

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.

Christophe Chaignot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.